Phase II trial of vindesine in malignant pleural mesothelioma

Cancer Treat Rep. 1987 Feb;71(2):205-6.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Drug Evaluation
  • Female
  • Humans
  • Male
  • Mesothelioma / drug therapy*
  • Mesothelioma / pathology
  • Middle Aged
  • Pleural Neoplasms / drug therapy*
  • Pleural Neoplasms / pathology
  • Vindesine / adverse effects
  • Vindesine / therapeutic use*

Substances

  • Vindesine